Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03856216
Title Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lymphoma

acute lymphoblastic leukemia

Therapies

Methotrexate

Filgrastim + Methotrexate + Rituximab

Rituximab

Bendamustine + Fludarabine + Inotuzumab ozogamicin + Tacrolimus

Filgrastim + Methotrexate

Inotuzumab ozogamicin

Fludarabine + Inotuzumab ozogamicin + Melphalan + Tacrolimus

anti-thymocyte globulin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.